Safety, Efficacy, and Biomarker Assessment of RP1 in Combination With Nivolumab in Patients with Advanced Skin Cancers

ANNALS OF SURGICAL ONCOLOGY(2023)

引用 0|浏览46
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要